ASIMICA
AsimicA focuses on developing novel technologies for improved production in Microbial Biosynthetic Factories. Their technologies have the potential for a multi-fold increase in yields of biosynthetic processes. Since relatively low yields of target products, made through the biosynthesis is the major limitation of biotechnology, our innovative approaches for production may revolutionize the industry. AsimicA was launched in November 2018, by Nikolai Mushnikov and Grant Bowman.
ASIMICA
Social Links:
Industry:
Biotechnology Life Science Medical
Founded:
2018-01-01
Address:
Wyoming, Michigan, United States
Country:
United States
Website Url:
http://www.asimica.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
250 K USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Apple Mobile Web Clips Icon Google Font API WordPress Google Maps Content Delivery Network Font Awesome JsDelivr Contact Form 7
Similar Organizations
Ajax Therapeutics
Ajax Therapeutics is a biotechnology company developing therapies to target cytokine signaling pathways that drive hematologic malignancies.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Current Employees Featured
Founder
Investors List
Official Site Inspections
http://www.asimica.com
- Host name: box5104.bluehost.com
- IP address: 162.241.244.22
- Location: Provo United States
- Latitude: 40.2342
- Longitude: -111.6442
- Metro Code: 770
- Timezone: America/Denver
- Postal: 84606
More informations about "AsimicA"
ASIMICA – Innovations in Microbial Biotechnologies
AsimicA is a B2B strain engineering company. Our partners are bigger biotech fermentation companies, which are producing industrial quantities of products through fermentation. In …See details»
AsimicA - Crunchbase Company Profile & Funding
AsimicA focuses on developing novel technologies for improved production in Microbial Biosynthetic Factories. Their technologies have the potential for a multi-fold increase in yields …See details»
AsimicA, Inc — Activate
The innovation of Microbial Stem Cells, designed by AsimicA, enables the desired stability of producing cultures to increase the economic efficiency of bio-production. FELLOW . Nikolai …See details»
Nikolai Mushnikov - Chief Executive Officer - AsimicA - LinkedIn
Chief Executive Officer at AsimicA · I'm a CEO and co-founder of AsimicA. We're designing novel approaches to improve the efficiency of microbial fermentation, using our innovation of …See details»
ASIMICA, INC. - VentureRadar
AsimicA was launched in November 2018 as a spin-off from the University research project. We focus on developing novel technologies for improved production in Microbial Biosynthetic …See details»
AsimicA - SOSV
AsimicA has developed technology to increase the productivity of microbial biosynthetic factories manyfold. Our microbial stem cells constantly replenish young factory cells in microbial …See details»
AsimicA - IndieBio - #1 in Early Stage Biotech
Asimica’s solution to this problem is to create microbial stem cells, a technology that constantly generates “young” and productive factory cells, which solves two problems: 1) it prolongs the …See details»
AsimicA 2025 Company Profile: Valuation, Funding & Investors
AsimicA General Information Description. Developer of novel technologies designed to boost production in microbial biosynthetic factories. The company's technology seeks to improve …See details»
ASIMICA LLC - National Science Foundation
Organization profile Current Congressional District. District n. 00 of Wyoming; Congressional Districts at Award . District n. 00 of Wyoming ... Dive into the research topics where ASIMICA …See details»
Our team – ASIMICA
The academic side of Asimica will be guided by Grant Bowman, an Associate Professor of Molecular Biology at the University of Wyoming and a co-inventor of MiST. The Bowman …See details»
Asimica - Alien Technology Transfer
AsimicA is a pioneering company specializing in Microbial Biosynthetic Factory solutions. The company’s expertise lies in solving the problem of low productivity in Microbial Biofactories. By …See details»
AsimicA: Raising the Bar for All Biofermentation - IndieBio
Oct 28, 2020 Today, we sit down with Nik Mushnikov, CEO and co-founder of AsimicA, whose technology promises to solve the bane of biomanufacturing: low yields that formerly could not …See details»
AsimicA: Raising the Bar for All Biofermentation - Medium
Oct 26, 2020 In May 2020, a McKinsey report found that the global bioeconomy is slated to become a $4 trillion gold rush as synthetic biology’s promise to make high-quality, sustainable …See details»
AsimicA - Funding, Financials, Valuation & Investors - Crunchbase
AsimicA focuses on developing novel technologies for improved production in Microbial Biosynthetic Factories.See details»
Contact – ASIMICA
Laramie Wyoming email: [email protected] ...See details»
AsimicA - Contacts, Employees, Board Members, Advisors & Alumni
AsimicA focuses on developing novel technologies for improved production in Microbial Biosynthetic Factories. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. …See details»
AsimicA - Updates, News, Events, Signals & Triggers - Crunchbase
Oct 28, 2020 AsimicA focuses on developing novel technologies for improved production in Microbial Biosynthetic Factories. New. Resources. Advanced Search ... Log In. Log In. …See details»
Mist – ASIMICA
The novel technology of AsimicA is a widely applicable genetic platform that is predicted to increase bioreactor yields by several-fold and could bring transformational advancements to …See details»
Gallery – ASIMICA
Mushnikov, N. V., Fomicheva, A., Gomelsky, M. & Bowman, G. R. Inducible asymmetric cell division and programmable cell differentiation in a bacterium.See details»
Subscribe – ASIMICA
Sign up to our newsletter. Submit. © 2023 by AsimicASee details»